Webster Veterinary Sees 33% Increase

Posted: Monday, June 29, 2009



Published:

Webster Veterinary, a unit of Patterson Companies Inc. of St. Paul, Minn., recently reported revenue of $158.5 million for its four quarter ended April 25, compared to revenue of $119.5 million in the year-ago period. The 33 percent increase is due primarily to the October acquisition of Columbus Serum.

Year to date, the unit reported revenue of $550.6 million, compared to revenue of $446.4 million in the year-ago period.

Overall, Patterson reported net income of $54 million on revenue of $779.9 million for its fourth quarter, compared to net income of $63.2 million on revenue of $778.4 million in the year-ago period.

Year to date, the company reported net income of $199.6 million on revenue of $3.1 billion, compared to net income of $224.9 million on revenue of $3 billion in the year-ago period.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Distributor MWI Sold to AmerisourceBergen

Despite the merger, President Jim Cleary and other executives will continue to manage MWI.

Zoetis Adds Abbott, Plans More Apoquel

It’s a busy time for Zoetis as the drug maker completes its purchase of Abbott Animal Health, reports higher sales and profits, and prepares for increased production of Apoquel.

Abaxis Enjoys Huge Jump in Sales, Profit

Partnering with distributors paid off for Abaxis, while competitor Idexx saw a small revenue dip while moving to direct sales.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module